These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. [Silent ischemic heart disease in patient with Wegener's necrotizing glomerulonephritis]. De la Prada FJ; Prados A; Ramos R; Munar MA; Losada P; Morey A Nefrologia; 2003; 23(6):545-9. PubMed ID: 15002790 [TBL] [Abstract][Full Text] [Related]
53. [Pharyngeal Wegener's disease: a case report]. Ayache S; Smail A; Stramandinoli E; Pichon JC; Strunski V Ann Otolaryngol Chir Cervicofac; 2001 Jun; 118(3):187-92. PubMed ID: 11431593 [TBL] [Abstract][Full Text] [Related]
54. [Severe chronic headache with depression induced by pachymeningitis in Wegener's granulomatosis]. von Bierbrauer A; Pelzer C; Fischer V Dtsch Med Wochenschr; 2008 Feb; 133(5):185-8. PubMed ID: 18213550 [TBL] [Abstract][Full Text] [Related]
55. Unusual pathogenesis of spontaneous pneumothorax secondary to Wegener's granulomatosis. Storelli E; Casali C; Natali P; Rossi G; Morandi U Ann Thorac Surg; 2007 Jul; 84(1):288-90. PubMed ID: 17588440 [TBL] [Abstract][Full Text] [Related]
56. Wegener's granulomatosis and subglottic stenosis: management of the airway. Alaani A; Hogg RP; Drake Lee AB J Laryngol Otol; 2004 Oct; 118(10):786-90. PubMed ID: 15550185 [TBL] [Abstract][Full Text] [Related]
57. Intravenous cyclophosphamide in patients with chronic systemic inflammatory diseases: morbidity and mortality. Gøransson LG; Brodin C; Ogreid P; Janssen EA; Romundstad PR; Vatten L; Wildhagen K; Kjellevold K; Omdal R Scand J Rheumatol; 2008; 37(2):130-4. PubMed ID: 18415771 [TBL] [Abstract][Full Text] [Related]
58. Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review. Monach PA; Arnold LM; Merkel PA Arthritis Rheum; 2010 Jan; 62(1):9-21. PubMed ID: 20039416 [No Abstract] [Full Text] [Related]